EP3541387
DOSE AND REGIMEN FOR HDM2-P53 INTERACTION INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.11.2017EP published:
21.4.2021EP application number:
17804304.8
EPO information:
European Patent Register
Max expiry date:
13.11.2037
Title:
DOSE AND REGIMEN FOR HDM2-P53 INTERACTION INHIBITORS
Timeline
Today
14.11.2017EP application
21.4.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
FERRETTI, StephaneAddress:
4002 Basel, CH
Name:
GUERREIRO, NelsonAddress:
4056 Basel, CH
Name:
JEAY, SebastienAddress:
4002 Basel, CH
Name:
JULLION, AstridAddress:
4056 Basel, CH
Name:
MEILLE, ChristopheAddress:
4056 Basel, CH
Name:
WUERTHNER, JensAddress:
4002 Basel, CH
Priority
Number:
201662422144 PDate:
15.11.2016Country:
US
Number:
201762479391 PDate:
31.3.2017Country:
US
Classification
Categories:
A61K 31/496, A61K 31/506, A61K 31/401, A61K 31/404, A61K 31/4418, A61K 31/4439, A61K 31/47, A61P 35/00